Saudi Arabia Smoking Tobacco Market Trends Alight Worldwide ... - Taiwan News
| 4166 Stock | TWD 36.55 0.45 1.22% |
Slightly above 61% of Orient Pharma's investor base is looking to short. The analysis of current outlook of investing in Orient Pharma Co suggests that many traders are alarmed regarding Orient Pharma's prospects. Orient Pharma's investing sentiment can be driven by a variety of factors including economic data, Orient Pharma's earnings reports, geopolitical events, and overall market trends.
Orient Pharma stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orient daily returns and investor perception about the current price of Orient Pharma Co as well as its diversification or hedging effects on your existing portfolios.
Orient |
Saudi Arabia Smoking Tobacco Market Trends Alight Worldwide ... Taiwan News
Read at news.google.com
 |
Orient Pharma Fundamental Analysis
We analyze Orient Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orient Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orient Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Orient Pharma is the top company in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Orient Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orient Pharma stock to make a market-neutral strategy. Peer analysis of Orient Pharma could also be used in its relative valuation, which is a method of valuing Orient Pharma by comparing valuation metrics with similar companies.
Peers
Orient Pharma Related Equities
| 1783 | Maxigen Biotech | 0.64 | ||||
| 8432 | Tsh Biopharmoration | 0.49 | ||||
| 4108 | Phytohealth Corp | 0.32 | ||||
| 4102 | Yung Zip | 0.17 | ||||
| 4166 | Orient Pharma | 1.22 |
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.